HEADER TRANSFERASE 22-SEP-09 2WTV TITLE AURORA-A INHIBITOR STRUCTURE CAVEAT 2WTV TPO A 287 CBETA WRONG HAND CAVEAT 2 2WTV TPO B 287 CBETA WRONG HAND CAVEAT 3 2WTV TPO C 287 CBETA WRONG HAND CAVEAT 4 2WTV TPO D 287 CBETA WRONG HAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1- COMPND 3 RELATED KINASE 1, BREAST TUMOR-AMPLIFIED KINASE, COMPND 4 AURORA-A, AURORA-RELATED KINASE 1, HARK1; COMPND 5 CHAIN: A, B, C, D; COMPND 6 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 122-403; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: CODONPLUS RPIL; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET M11 KEYWDS KINASE, CELL CYCLE, TRANSFERASE, PHOSPHOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.KOSMOPOULOU,R.BAYLISS REVDAT 2 21-APR-10 2WTV 1 JRNL REMARK REVDAT 1 26-JAN-10 2WTV 0 JRNL AUTH C.A.DODSON,M.KOSMOPOULOU,M.W.RICHARDS,B.ATRASH, JRNL AUTH 2 V.BAVETSIAS,J.BLAGG,R.BAYLISS JRNL TITL CRYSTAL STRUCTURE OF AN AURORA-A MUTANT THAT JRNL TITL 2 MIMICS AURORA-B BOUND TO MLN8054: INSIGHTS INTO JRNL TITL 3 SELECTIVITY AND DRUG DESIGN. JRNL REF BIOCHEM.J. V. 427 19 2010 JRNL REFN ISSN 0264-6021 JRNL PMID 20067443 JRNL DOI 10.1042/BJ20091530 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 79206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 FREE R VALUE TEST SET COUNT : 3969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.7851 - 7.1745 0.99 2830 150 0.1526 0.1500 REMARK 3 2 7.1745 - 5.7404 1.00 2811 159 0.1643 0.2038 REMARK 3 3 5.7404 - 5.0284 0.99 2783 162 0.1521 0.2017 REMARK 3 4 5.0284 - 4.5749 1.00 2837 128 0.1188 0.1440 REMARK 3 5 4.5749 - 4.2504 0.99 2819 142 0.1152 0.1505 REMARK 3 6 4.2504 - 4.0020 0.99 2833 142 0.1144 0.1473 REMARK 3 7 4.0020 - 3.8031 0.99 2812 146 0.1250 0.1744 REMARK 3 8 3.8031 - 3.6386 0.99 2837 163 0.1275 0.1523 REMARK 3 9 3.6386 - 3.4993 0.99 2779 151 0.1354 0.1794 REMARK 3 10 3.4993 - 3.3792 0.98 2769 155 0.1412 0.1923 REMARK 3 11 3.3792 - 3.2740 0.98 2828 138 0.1520 0.2115 REMARK 3 12 3.2740 - 3.1808 0.98 2769 140 0.1552 0.2216 REMARK 3 13 3.1808 - 3.0974 0.97 2751 160 0.1578 0.1868 REMARK 3 14 3.0974 - 3.0221 0.97 2732 151 0.1673 0.2196 REMARK 3 15 3.0221 - 2.9536 0.97 2742 152 0.1826 0.2395 REMARK 3 16 2.9536 - 2.8909 0.95 2661 138 0.1863 0.2392 REMARK 3 17 2.8909 - 2.8333 0.95 2709 142 0.1856 0.2294 REMARK 3 18 2.8333 - 2.7800 0.95 2708 132 0.1846 0.2577 REMARK 3 19 2.7800 - 2.7304 0.94 2674 149 0.2010 0.2528 REMARK 3 20 2.7304 - 2.6843 0.92 2625 128 0.1963 0.2845 REMARK 3 21 2.6843 - 2.6411 0.92 2596 136 0.1989 0.2292 REMARK 3 22 2.6411 - 2.6005 0.90 2599 138 0.1992 0.2811 REMARK 3 23 2.6005 - 2.5624 0.89 2485 146 0.2140 0.2862 REMARK 3 24 2.5624 - 2.5264 0.88 2521 119 0.2247 0.3002 REMARK 3 25 2.5264 - 2.4923 0.88 2547 117 0.2283 0.3267 REMARK 3 26 2.4923 - 2.4600 0.85 2423 122 0.2270 0.3180 REMARK 3 27 2.4600 - 2.4293 0.85 2378 119 0.2326 0.3365 REMARK 3 28 2.4293 - 2.4001 0.83 2379 144 0.2235 0.2993 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 51.14 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.69810 REMARK 3 B22 (A**2) : 5.69810 REMARK 3 B33 (A**2) : -11.39610 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 9127 REMARK 3 ANGLE : 1.046 12330 REMARK 3 CHIRALITY : 0.066 1288 REMARK 3 PLANARITY : 0.004 1555 REMARK 3 DIHEDRAL : 21.467 3396 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WTV COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-SEP-09. REMARK 100 THE PDBE ID CODE IS EBI-41214. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9334 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 83351 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 59.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OL7 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M NAH2PO4 1.2M K2HPO4 0.1M NA REMARK 280 ACETATE, PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.29667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.59333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 215 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 217 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 220 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LEU 215 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN B, THR 217 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 220 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN C, LEU 215 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN C, THR 217 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ARG 220 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN D, LEU 215 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN D, THR 217 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN D, ARG 220 TO LYS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 119 REMARK 465 ALA A 120 REMARK 465 MET A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 465 GLY B 120 REMARK 465 ALA B 121 REMARK 465 MET B 122 REMARK 465 GLU B 122 REMARK 465 SER B 123 REMARK 465 LYS B 124 REMARK 465 LYS B 125 REMARK 465 PRO B 390 REMARK 465 SER B 391 REMARK 465 ASN B 392 REMARK 465 CYS B 393 REMARK 465 GLN B 394 REMARK 465 ASN B 395 REMARK 465 LYS B 396 REMARK 465 GLU B 397 REMARK 465 SER B 398 REMARK 465 ALA B 399 REMARK 465 SER B 400 REMARK 465 LYS B 401 REMARK 465 GLN B 402 REMARK 465 SER B 403 REMARK 465 GLY C 120 REMARK 465 ALA C 121 REMARK 465 GLU C 122 REMARK 465 MET C 122 REMARK 465 SER C 123 REMARK 465 LYS C 124 REMARK 465 LYS C 125 REMARK 465 PRO C 390 REMARK 465 SER C 391 REMARK 465 ASN C 392 REMARK 465 CYS C 393 REMARK 465 GLN C 394 REMARK 465 ASN C 395 REMARK 465 LYS C 396 REMARK 465 GLU C 397 REMARK 465 SER C 398 REMARK 465 ALA C 399 REMARK 465 SER C 400 REMARK 465 LYS C 401 REMARK 465 GLN C 402 REMARK 465 SER C 403 REMARK 465 GLY D 119 REMARK 465 ALA D 120 REMARK 465 MET D 121 REMARK 465 GLU D 122 REMARK 465 SER D 123 REMARK 465 LYS D 124 REMARK 465 PRO D 390 REMARK 465 SER D 391 REMARK 465 ASN D 392 REMARK 465 CYS D 393 REMARK 465 GLN D 394 REMARK 465 ASN D 395 REMARK 465 LYS D 396 REMARK 465 GLU D 397 REMARK 465 SER D 398 REMARK 465 ALA D 399 REMARK 465 SER D 400 REMARK 465 LYS D 401 REMARK 465 GLN D 402 REMARK 465 SER D 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 156 CD CE NZ REMARK 470 LYS A 326 CD CE NZ REMARK 470 ARG A 375 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 126 NH1 NH2 REMARK 470 GLN B 127 CG CD OE1 NE2 REMARK 470 ARG B 251 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 339 CG CD CE NZ REMARK 470 GLU B 354 CD OE1 OE2 REMARK 470 ARG B 375 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 126 NH1 NH2 REMARK 470 GLN C 127 CG CD OE1 NE2 REMARK 470 ARG C 189 CZ NH1 NH2 REMARK 470 GLN C 335 CD OE1 NE2 REMARK 470 LYS C 339 CG CD CE NZ REMARK 470 ARG C 375 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 141 CE NZ REMARK 470 ARG D 179 CD NE CZ NH1 NH2 REMARK 470 LYS D 326 CD CE NZ REMARK 470 LYS D 339 CG CD CE NZ REMARK 470 ARG D 375 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG B 126 NE ARG B 126 CZ 0.169 REMARK 500 ARG C 126 NE ARG C 126 CZ 0.170 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 126 CD - NE - CZ ANGL. DEV. = -13.1 DEGREES REMARK 500 ARG C 126 CD - NE - CZ ANGL. DEV. = -11.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 156 23.51 49.96 REMARK 500 ASP A 202 -155.45 -117.75 REMARK 500 SER A 226 -45.02 80.11 REMARK 500 ASP A 307 -155.64 -139.74 REMARK 500 LEU A 364 46.34 -93.79 REMARK 500 SER B 226 -39.90 77.85 REMARK 500 CME B 290 1.50 85.02 REMARK 500 VAL B 344 52.23 39.67 REMARK 500 SER C 226 -44.64 76.67 REMARK 500 TPO C 288 -168.92 -161.90 REMARK 500 CME C 290 1.21 85.46 REMARK 500 HIS C 306 134.71 -171.23 REMARK 500 ASP D 202 -161.71 -116.39 REMARK 500 SER D 226 -46.61 74.47 REMARK 500 LEU D 364 41.88 -90.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 TPO A 287 -34.9 R S CBETA WRONG HAND REMARK 500 TPO B 287 -34.8 R S CBETA WRONG HAND REMARK 500 TPO C 287 -34.0 R S CBETA WRONG HAND REMARK 500 TPO D 287 -33.9 R S CBETA WRONG HAND REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZL A1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1392 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1393 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A1394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZL B1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS B1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B1392 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B1393 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1394 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1395 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1396 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1397 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1398 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B1399 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B1400 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZL C1392 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C1393 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C1394 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C1395 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZL D1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO D1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D1392 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D1393 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC REMARK 900 SERINE-THREONINE KINASE REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -739358 REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF REMARK 900 AURORA-A REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- REMARK 900 680632 REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH A 5-AMINOPYRIMIDINYL REMARK 900 QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA REMARK 900 -680626 REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, REMARK 900 PHOSPHORYLATED ON THR287, THR288 AND BOUND REMARK 900 TO TPX2 1-43 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN REMARK 900 COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2WTW RELATED DB: PDB REMARK 900 AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL REMARK 900 FORM) REMARK 900 RELATED ID: 2WQE RELATED DB: PDB REMARK 900 STRUCTURE OF S155R AURORA-A SOMATIC MUTANT REMARK 900 RELATED ID: 2W1C RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 REMARK 900 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN REMARK 900 COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE DBREF 2WTV A 119 121 PDB 2WTV 2WTV 119 121 DBREF 2WTV A 122 403 UNP O14965 STK6_HUMAN 122 403 DBREF 2WTV B 120 122 PDB 2WTV 2WTV 120 122 DBREF 2WTV B 122 403 UNP O14965 STK6_HUMAN 122 403 DBREF 2WTV C 120 122 PDB 2WTV 2WTV 120 122 DBREF 2WTV C 122 403 UNP O14965 STK6_HUMAN 122 403 DBREF 2WTV D 119 121 PDB 2WTV 2WTV 119 121 DBREF 2WTV D 122 403 UNP O14965 STK6_HUMAN 122 403 SEQADV 2WTV ARG A 215 UNP O14965 LEU 215 ENGINEERED MUTATION SEQADV 2WTV GLU A 217 UNP O14965 THR 217 ENGINEERED MUTATION SEQADV 2WTV LYS A 220 UNP O14965 ARG 220 ENGINEERED MUTATION SEQADV 2WTV ARG B 215 UNP O14965 LEU 215 ENGINEERED MUTATION SEQADV 2WTV GLU B 217 UNP O14965 THR 217 ENGINEERED MUTATION SEQADV 2WTV LYS B 220 UNP O14965 ARG 220 ENGINEERED MUTATION SEQADV 2WTV ARG C 215 UNP O14965 LEU 215 ENGINEERED MUTATION SEQADV 2WTV GLU C 217 UNP O14965 THR 217 ENGINEERED MUTATION SEQADV 2WTV LYS C 220 UNP O14965 ARG 220 ENGINEERED MUTATION SEQADV 2WTV ARG D 215 UNP O14965 LEU 215 ENGINEERED MUTATION SEQADV 2WTV GLU D 217 UNP O14965 THR 217 ENGINEERED MUTATION SEQADV 2WTV LYS D 220 UNP O14965 ARG 220 ENGINEERED MUTATION SEQRES 1 A 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 A 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 A 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 A 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 A 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 A 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 A 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 A 285 LEU GLU TYR ALA PRO ARG GLY GLU VAL TYR LYS GLU LEU SEQRES 9 A 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 A 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 A 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 A 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 A 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG TPO SEQRES 14 A 285 TPO LEU CME GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 A 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 A 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 A 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 A 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 A 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 A 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 A 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 A 285 ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER SEQRES 1 B 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 B 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 B 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 B 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 B 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 B 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 B 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 B 285 LEU GLU TYR ALA PRO ARG GLY GLU VAL TYR LYS GLU LEU SEQRES 9 B 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 B 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 B 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 B 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 B 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG TPO SEQRES 14 B 285 TPO LEU CME GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 B 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 B 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 B 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 B 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 B 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 B 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 B 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 B 285 ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER SEQRES 1 C 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 C 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 C 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 C 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 C 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 C 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 C 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 C 285 LEU GLU TYR ALA PRO ARG GLY GLU VAL TYR LYS GLU LEU SEQRES 9 C 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 C 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 C 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 C 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 C 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG TPO SEQRES 14 C 285 TPO LEU CME GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 C 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 C 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 C 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 C 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 C 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 C 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 C 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 C 285 ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER SEQRES 1 D 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 D 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 D 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 D 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 D 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 D 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 D 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 D 285 LEU GLU TYR ALA PRO ARG GLY GLU VAL TYR LYS GLU LEU SEQRES 9 D 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 D 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 D 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 D 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 D 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG TPO SEQRES 14 D 285 TPO LEU CME GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 D 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 D 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 D 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 D 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 D 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 D 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 D 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 D 285 ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER MODRES 2WTV TPO A 287 THR PHOSPHOTHREONINE MODRES 2WTV TPO A 288 THR PHOSPHOTHREONINE MODRES 2WTV CME A 290 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2WTV TPO B 287 THR PHOSPHOTHREONINE MODRES 2WTV TPO B 288 THR PHOSPHOTHREONINE MODRES 2WTV CME B 290 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2WTV TPO C 287 THR PHOSPHOTHREONINE MODRES 2WTV TPO C 288 THR PHOSPHOTHREONINE MODRES 2WTV CME C 290 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 2WTV TPO D 287 THR PHOSPHOTHREONINE MODRES 2WTV TPO D 288 THR PHOSPHOTHREONINE MODRES 2WTV CME D 290 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET ZZL A1390 34 HET EDO A1391 4 HET ACT A1392 4 HET ACT A1393 4 HET TPO A 287 11 HET TPO A 288 11 HET CME A 290 10 HET DMS A1394 4 HET EDO C1390 4 HET ZZL B1390 34 HET DMS B1391 4 HET ACT B1392 4 HET ACT B1393 4 HET EDO B1394 4 HET EDO B1395 4 HET EDO B1396 4 HET EDO B1397 4 HET EDO B1398 4 HET EDO B1399 4 HET TPO B 287 11 HET TPO B 288 11 HET CME B 290 10 HET EDO C1391 4 HET ACT B1400 4 HET ZZL C1392 34 HET ACT C1393 4 HET ACT C1394 4 HET EDO C1395 4 HET TPO C 287 11 HET TPO C 288 11 HET CME C 290 10 HET ZZL D1390 34 HET EDO D1391 4 HET ACT D1392 4 HET ACT D1393 4 HET TPO D 287 11 HET TPO D 288 11 HET CME D 290 10 HETNAM TPO PHOSPHOTHREONINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ZZL 4-{[9-CHLORO-7-(2,6-DIFLUOROPHENYL)-5H- HETNAM 2 ZZL PYRIMIDO[5,4-D][2]BENZAZEPIN-2-YL]AMINO}BENZOIC HETNAM 3 ZZL ACID HETNAM DMS DIMETHYL SULFOXIDE HETNAM EDO 1,2-ETHANEDIOL HETNAM ACT ACETATE ION HETSYN TPO PHOSPHONOTHREONINE HETSYN EDO ETHYLENE GLYCOL FORMUL 5 TPO 8(C4 H10 N O6 P) FORMUL 6 CME 4(C5 H11 N O3 S2) FORMUL 7 ZZL 4(C25 H15 CL F2 N4 O2) FORMUL 8 DMS 2(C2 H6 O S) FORMUL 9 EDO 11(C2 H6 O2) FORMUL 10 ACT 9(C2 H3 O2 1-) FORMUL 11 HOH *743(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 GLU A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 THR A 292 LEU A 296 5 5 HELIX 8 8 PRO A 297 GLU A 302 1 6 HELIX 9 9 GLU A 308 LEU A 315 1 8 HELIX 10 10 VAL A 317 VAL A 324 1 8 HELIX 11 11 THR A 333 ARG A 343 1 11 HELIX 12 12 ALA A 356 LEU A 364 1 9 HELIX 13 13 ASN A 367 ARG A 371 5 5 HELIX 14 14 MET A 373 GLU A 379 1 7 HELIX 15 15 HIS A 380 SER A 387 1 8 HELIX 16 16 ALA B 129 GLU B 131 5 3 HELIX 17 17 LYS B 166 ALA B 172 1 7 HELIX 18 18 VAL B 174 SER B 186 1 13 HELIX 19 19 GLU B 217 SER B 226 1 10 HELIX 20 20 ASP B 229 LYS B 250 1 22 HELIX 21 21 LYS B 258 GLU B 260 5 3 HELIX 22 22 THR B 292 LEU B 296 5 5 HELIX 23 23 PRO B 297 GLU B 302 1 6 HELIX 24 24 LYS B 309 LEU B 315 1 7 HELIX 25 25 VAL B 317 VAL B 324 1 8 HELIX 26 26 THR B 333 ARG B 343 1 11 HELIX 27 27 ALA B 356 LEU B 364 1 9 HELIX 28 28 ASN B 367 ARG B 371 5 5 HELIX 29 29 MET B 373 GLU B 379 1 7 HELIX 30 30 HIS B 380 SER B 387 1 8 HELIX 31 31 ALA C 129 GLU C 131 5 3 HELIX 32 32 LYS C 166 ALA C 172 1 7 HELIX 33 33 VAL C 174 SER C 186 1 13 HELIX 34 34 GLU C 217 SER C 226 1 10 HELIX 35 35 ASP C 229 LYS C 250 1 22 HELIX 36 36 LYS C 258 GLU C 260 5 3 HELIX 37 37 THR C 292 LEU C 296 5 5 HELIX 38 38 PRO C 297 GLU C 302 1 6 HELIX 39 39 LYS C 309 LEU C 315 1 7 HELIX 40 40 VAL C 317 VAL C 324 1 8 HELIX 41 41 THR C 333 ARG C 343 1 11 HELIX 42 42 ALA C 356 LEU C 364 1 9 HELIX 43 43 ASN C 367 ARG C 371 5 5 HELIX 44 44 MET C 373 GLU C 379 1 7 HELIX 45 45 HIS C 380 SER C 387 1 8 HELIX 46 46 ALA D 129 GLU D 131 5 3 HELIX 47 47 LYS D 166 ALA D 172 1 7 HELIX 48 48 VAL D 174 HIS D 187 1 14 HELIX 49 49 GLU D 217 SER D 226 1 10 HELIX 50 50 ASP D 229 LYS D 250 1 22 HELIX 51 51 LYS D 258 GLU D 260 5 3 HELIX 52 52 THR D 292 LEU D 296 5 5 HELIX 53 53 PRO D 297 GLU D 302 1 6 HELIX 54 54 GLU D 308 LEU D 315 1 8 HELIX 55 55 VAL D 317 VAL D 324 1 8 HELIX 56 56 THR D 333 VAL D 344 1 12 HELIX 57 57 ALA D 356 LEU D 364 1 9 HELIX 58 58 ASN D 367 ARG D 371 5 5 HELIX 59 59 MET D 373 GLU D 379 1 7 HELIX 60 60 HIS D 380 SER D 387 1 8 SHEET 1 AA 5 PHE A 133 GLU A 134 0 SHEET 2 AA 5 VAL A 147 GLU A 152 -1 O ARG A 151 N GLU A 134 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 PHE A 200 HIS A 201 -1 O PHE A 200 N TYR A 207 SHEET 1 AB 2 LEU A 262 LEU A 263 0 SHEET 2 AB 2 LYS A 271 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 BA 5 PHE B 133 GLU B 134 0 SHEET 2 BA 5 VAL B 147 GLU B 152 -1 O ARG B 151 N GLU B 134 SHEET 3 BA 5 ILE B 158 PHE B 165 -1 O LEU B 159 N ALA B 150 SHEET 4 BA 5 ARG B 205 GLU B 211 -1 O VAL B 206 N LEU B 164 SHEET 5 BA 5 PHE B 200 HIS B 201 -1 O PHE B 200 N TYR B 207 SHEET 1 BB 2 LEU B 262 LEU B 263 0 SHEET 2 BB 2 LYS B 271 ILE B 272 -1 O LYS B 271 N LEU B 263 SHEET 1 CA 5 PHE C 133 GLU C 134 0 SHEET 2 CA 5 VAL C 147 GLU C 152 -1 O ARG C 151 N GLU C 134 SHEET 3 CA 5 ILE C 158 PHE C 165 -1 O LEU C 159 N ALA C 150 SHEET 4 CA 5 ARG C 205 LEU C 210 -1 O VAL C 206 N LEU C 164 SHEET 5 CA 5 PHE C 200 HIS C 201 -1 O PHE C 200 N TYR C 207 SHEET 1 CB 2 LEU C 262 LEU C 263 0 SHEET 2 CB 2 LYS C 271 ILE C 272 -1 O LYS C 271 N LEU C 263 SHEET 1 DA 5 PHE D 133 GLU D 134 0 SHEET 2 DA 5 VAL D 147 GLU D 152 -1 O ARG D 151 N GLU D 134 SHEET 3 DA 5 ILE D 158 PHE D 165 -1 O LEU D 159 N ALA D 150 SHEET 4 DA 5 ARG D 205 LEU D 210 -1 O VAL D 206 N LEU D 164 SHEET 5 DA 5 PHE D 200 HIS D 201 -1 O PHE D 200 N TYR D 207 SHEET 1 DB 2 LEU D 262 LEU D 263 0 SHEET 2 DB 2 LYS D 271 ILE D 272 -1 O LYS D 271 N LEU D 263 LINK C ARG A 286 N TPO A 287 1555 1555 1.32 LINK C TPO A 287 N TPO A 288 1555 1555 1.33 LINK C TPO A 288 N LEU A 289 1555 1555 1.33 LINK C LEU A 289 N CME A 290 1555 1555 1.33 LINK C CME A 290 N GLY A 291 1555 1555 1.33 LINK C ARG B 286 N TPO B 287 1555 1555 1.32 LINK C TPO B 287 N TPO B 288 1555 1555 1.33 LINK C TPO B 288 N LEU B 289 1555 1555 1.33 LINK C LEU B 289 N CME B 290 1555 1555 1.33 LINK C CME B 290 N GLY B 291 1555 1555 1.33 LINK C ARG C 286 N TPO C 287 1555 1555 1.32 LINK C TPO C 287 N TPO C 288 1555 1555 1.33 LINK C TPO C 288 N LEU C 289 1555 1555 1.33 LINK C LEU C 289 N CME C 290 1555 1555 1.33 LINK C CME C 290 N GLY C 291 1555 1555 1.33 LINK C ARG D 286 N TPO D 287 1555 1555 1.32 LINK C TPO D 287 N TPO D 288 1555 1555 1.33 LINK C TPO D 288 N LEU D 289 1555 1555 1.33 LINK C LEU D 289 N CME D 290 1555 1555 1.33 LINK C CME D 290 N GLY D 291 1555 1555 1.33 SITE 1 AC1 18 GLY A 140 VAL A 147 LYS A 162 LEU A 194 SITE 2 AC1 18 GLU A 211 TYR A 212 ALA A 213 ASN A 261 SITE 3 AC1 18 LEU A 263 ALA A 273 ASP A 274 VAL A 279 SITE 4 AC1 18 ACT A1392 HOH A2015 HOH A2072 HOH A2111 SITE 5 AC1 18 HOH A2163 LYS C 171 SITE 1 AC2 4 GLN A 231 ALA A 385 ASN A 386 SER A 387 SITE 1 AC3 5 GLU A 217 GLU A 260 VAL A 279 ZZL A1390 SITE 2 AC3 5 HOH A2164 SITE 1 AC4 4 HIS A 248 MET A 373 LEU A 374 HOH A2165 SITE 1 AC5 3 TYR A 148 ARG A 205 PRO C 138 SITE 1 AC6 6 ASN A 146 TYR A 148 GLY C 136 ARG C 137 SITE 2 AC6 6 HOH C2190 HOH C2191 SITE 1 AC7 15 LEU B 139 LYS B 141 VAL B 147 LYS B 162 SITE 2 AC7 15 LEU B 194 GLU B 211 TYR B 212 ALA B 213 SITE 3 AC7 15 ASN B 261 LEU B 263 ALA B 273 ASP B 274 SITE 4 AC7 15 PHE B 275 ACT B1393 HOH B2101 SITE 1 AC8 3 PRO B 138 TYR D 148 ARG D 205 SITE 1 AC9 5 ASP B 256 LYS B 258 GLY B 291 THR B 292 SITE 2 AC9 5 HOH B2192 SITE 1 BC1 5 GLU B 217 LYS B 220 VAL B 279 ZZL B1390 SITE 2 BC1 5 HOH B2193 SITE 1 BC2 4 EDO B1399 HOH B2194 HOH B2195 ASN D 146 SITE 1 BC3 4 GLU B 170 GLY B 173 GLU B 175 HIS B 176 SITE 1 BC4 1 HIS B 201 SITE 1 BC5 3 ASP B 202 ALA B 203 THR B 204 SITE 1 BC6 6 HIS B 280 ALA B 281 TPO B 287 SER D 266 SITE 2 BC6 6 GLU D 269 HOH D2131 SITE 1 BC7 5 GLY B 136 ARG B 137 EDO B1394 ASN D 146 SITE 2 BC7 5 TYR D 148 SITE 1 BC8 8 ASP B 229 GLN B 231 HOH B2074 ASP C 229 SITE 2 BC8 8 GLN C 231 ARG C 232 HOH C2193 HOH C2194 SITE 1 BC9 6 HIS B 248 LYS B 309 MET B 373 LEU B 374 SITE 2 BC9 6 HOH B2196 HOH B2197 SITE 1 CC1 16 LEU C 139 LYS C 141 VAL C 147 LYS C 162 SITE 2 CC1 16 LEU C 194 GLU C 211 TYR C 212 ALA C 213 SITE 3 CC1 16 ASN C 261 LEU C 263 ALA C 273 ASP C 274 SITE 4 CC1 16 PHE C 275 VAL C 279 ACT C1394 HOH C2100 SITE 1 CC2 5 HIS C 248 LYS C 309 MET C 373 LEU C 374 SITE 2 CC2 5 HOH C2196 SITE 1 CC3 4 GLU C 217 LYS C 220 ZZL C1392 HOH C2064 SITE 1 CC4 5 ASP C 256 LYS C 258 GLY C 291 THR C 292 SITE 2 CC4 5 HOH C2197 SITE 1 CC5 17 LYS B 171 GLY D 140 VAL D 147 LYS D 162 SITE 2 CC5 17 LEU D 194 GLU D 211 TYR D 212 ALA D 213 SITE 3 CC5 17 ASN D 261 LEU D 263 ALA D 273 ASP D 274 SITE 4 CC5 17 VAL D 279 ACT D1392 HOH D2017 HOH D2132 SITE 5 CC5 17 HOH D2179 SITE 1 CC6 4 PHE D 346 PHE D 348 HOH D2180 HOH D2181 SITE 1 CC7 5 GLU D 217 GLU D 260 VAL D 279 ZZL D1390 SITE 2 CC7 5 HOH D2182 SITE 1 CC8 5 HIS D 248 LYS D 309 LEU D 374 HOH D2183 SITE 2 CC8 5 HOH D2184 CRYST1 118.707 118.707 135.890 90.00 90.00 120.00 P 31 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008424 0.004864 0.000000 0.00000 SCALE2 0.000000 0.009727 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007359 0.00000